TASP1 is deleted in an infant with developmental delay, microcephaly, distinctive facial features, and multiple congenital anomalies

Clin Genet. 2018 Jul;94(1):170-173. doi: 10.1111/cge.13258. Epub 2018 May 10.

Abstract

We report a 20p12.1 homozygous deletion including exons 5-10 of the TASP1 gene in an infant with developmental delay, acquired microcephaly, distinctive facial features, and multiple congenital anomalies involving skeletal, cardiac, and renal systems. TASP1 encodes taspase 1 which is responsible for cleaving, thus activating, a number of transcription factors including the mixed lineage leukemia 1 (MLL1). Taspase 1-deficient mice showed early lethality, skeletal abnormalities, and growth failure, which support a potentially causal role of TASP1 deletion in this infant. Furthermore, the infant reported here had many of the features seen in Wiedemann-Steiner syndrome which is caused by MLL1 defects. Such observation further supports that TASP1 is a novel disease-related gene that is associated with a disease phenotype overlapping with Wiedemann-Steiner syndrome as both are caused by defects in the same pathway.

Keywords: TASP1; Wiedemann-Steiner syndrome; chromosomal microarray; novel gene; taspase 1; transcription factor.

MeSH terms

  • Comparative Genomic Hybridization
  • Congenital Abnormalities / diagnosis
  • Congenital Abnormalities / genetics*
  • Developmental Disabilities / diagnosis
  • Developmental Disabilities / genetics*
  • Endopeptidases / genetics*
  • Facies*
  • Female
  • Gene Deletion*
  • Humans
  • Infant
  • Male
  • Microcephaly / diagnosis
  • Microcephaly / genetics*
  • Phenotype*
  • Polymorphism, Single Nucleotide
  • Syndrome

Substances

  • Endopeptidases
  • taspase1, human